Clincosm LogoSign in Get a demo

ABCIP: Advisory Board on Cancer, Infertility and Pregnancy

Sponsor
University Hospital, Gasthuisberg (Other)
Overall Status
Recruiting
CT.gov ID
NCT04904263
Collaborator
Kom Op Tegen Kanker (Other), European Research Council (Other)
100
Enrollment
1
Location
36
Anticipated Duration (Months)
2.8
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The Advisory Board on Cancer, Infertility and Pregnancy provides a platform where physicians from all over the world can request recommendations regarding the medical care of pregnant women diagnosed with cancer or regarding fertility preservation. The platform will contain different national advisory boards, with their own coordinator and members, as well as an overarching international advisory board with an international coordinator and members from different national boards.

To investigate the impact of this platform, a year after its launch, data regarding the incoming requests will be extracted from the website, as well as all recommendation letters.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The Advisory Board on Cancer, Infertility and Pregnancy (ABCIP)-platform will be a web-based platform where clinicians from all over the world can request advice from a group of experts on the field of Cancer and Pregnancy. The platform will contain different national advisory boards, with their own coordinator and members, as well as an overarching international advisory board with an international coordinator and members from different national boards.

    Clinicians can fill in a format (attached) requesting for advice, using only pseudonymized patient data after agreeing a disclaimer:

    All information filled in in the 'request advice' format needs to be regarded as anonymous or pseudonymous data. We recommend you to inform your patient and ask for approval when needed, based on the rules and regulations applicable in your country.

    The filled out request will be sent to the specific national board of their own country, and if no national board is available, to the overarching international board.

    . To investigate the impact of this platform, a year after its launch, data regarding the incoming requests will be extracted from the website, as well as all recommendation letters.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    100 participants
    Observational Model:
    Other
    Time Perspective:
    Other
    Official Title:
    Advisory Board on Cancer, Infertility and Pregnancy
    Anticipated Study Start Date :
    May 22, 2021
    Anticipated Primary Completion Date :
    May 22, 2024
    Anticipated Study Completion Date :
    May 22, 2024

    Outcome Measures

    Primary Outcome Measures

    1. The impact of an international advisory board on cancer in pregnancy [1 year]

      To investigate the impact of this platform, a year after its launch, data regarding the incoming requests will be extracted from the website, as well as all recommendation letters. All requesting physicians will be asked to complete a survey including their experiences with the ABCIP, to what amount they followed the given recommendations and the outcomes of mother (and child)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • Pregnant women with a cancer diagnosis

    • Women with a fertility related question after cancer diagnosis

    • Postpartum cancer diagnosis

    • Cancer treatment during pregnancy

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 UZ Gasthuisberg, Katholieke Universiteit Leuven Leuven Belgium 3000

    Sponsors and Collaborators

    • University Hospital, Gasthuisberg
    • Kom Op Tegen Kanker
    • European Research Council

    Investigators

    • Principal Investigator: Frederic Amant, MD,PhD, Universitaire Ziekenhuizen Leuven

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Frederic Amant, Prof. dr. Amant, University Hospital, Gasthuisberg
    ClinicalTrials.gov Identifier:
    NCT04904263
    Other Study ID Numbers:
    • ABCIP
    First Posted:
    May 27, 2021
    Last Update Posted:
    May 27, 2021
    Last Verified:
    May 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Frederic Amant, Prof. dr. Amant, University Hospital, Gasthuisberg
    Cancer in Pregnancy
    Fertility preservation
    Additional relevant MeSH terms:
    Infertility

    Study Results

    No Results Posted as of May 27, 2021